Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26537991 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Abdominal pain, Abdominal pain upper, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Blister, Breast cancer stage III, Chest pain, Condition aggravated, Decreased appetite, Diarrhoea, Disability, Dizziness, Duodenal ulcer perforation, Dyspnoea, Nausea, Pruritus, Osteoarthritis, Pneumonia, Product use issue, Fatigue, Bronchitis, Grip strength decreased, Oedema, Drug hypersensitivity, Seronegative arthritis, Gait disturbance, Intentional product use issue, Insomnia, Adverse drug reaction, Therapeutic product effect incomplete, Amnesia, Therapeutic response decreased, Pyrexia, Treatment failure, Adjustment disorder with depressed mood, Liver function test increased, Muscular weakness, Dislocation of vertebra, Therapeutic product effect decreased, Upper respiratory tract infection, Hepatic enzyme increased, Foot deformity, Sciatica, Spondylitis, Mobility decreased, Oedema peripheral, Musculoskeletal stiffness, Rheumatic fever, Injury, Joint dislocation, Sinusitis, Headache, Swollen joint count increased, Delirium, Visual impairment, Weight decreased, C-reactive protein increased, Hypersensitivity, Osteoporosis, Discomfort, Tachycardia, Hypertension, Contraindicated product administered, Joint range of motion decreased, Drug tolerance decreased, Retinitis, Blood cholesterol increased, Depression, Drug-induced liver injury, Drug ineffective, Vomiting, Helicobacter infection, Hypoaesthesia, Infection, Infusion related reaction, Joint swelling, Live birth, Liver injury, Malaise, Maternal exposure during pregnancy, Memory impairment, Muscle injury, Off label use, Pain, Pemphigus, Pericarditis, Peripheral swelling, Product use in unapproved indication, Psoriasis, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Abdominal discomfort, Walking aid user, Wheezing, Wound, Wound infection, Exposure during pregnancy, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Prescribed overdose, Rheumatoid factor positive, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Therapy non-responder, Treatment noncompliance, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CANDESARTAN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, SARILUMAB, PREGABALIN, PREGABALIN, PREDNISONE, TRIPROLIDINE HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, OXYCODONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, VITAMIN C, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, FOLIC ACID, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ETANERCEPT, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, APREMILAST, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, NAPROXEN, NAPROXEN SODIUM, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREGABALIN, SARILUMAB, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VEDOLIZUMAB, |
||||
| 102 | 26538027 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 103 | 26538028 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 104 | 26538050 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 105 | 26538092 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 106 | 26538140 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 107 | 26538143 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 108 | 26538385 |
GB |
1 | |
General physical health deterioration, Malaise, Lethargy, Sepsis, Acute kidney injury, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, |
||||
| 109 | 26538647 |
US |
2 | |
Pneumonia, Bronchospasm, Dyspnoea at rest, Dyspnoea exertional, Weight decreased, General physical health deterioration, Decreased activity, Dyspnoea, Cough, Depression, Drug ineffective, |
||||
ENSIFENTRINE, ENSIFENTRINE, ENSIFENTRINE, ENSIFENTRINE, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, BUDESONIDE, REVEFENACIN, SELEXIPAG, ROFLUMILAST, ROSUVASTATIN, EZETIMIBE, PREDNISONE, MONTELUKAST, DUPILUMAB, |
||||
| 110 | 26538677 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 111 | 26538876 |
EU |
53 | 2 |
Death, Cachexia, Blood lactate dehydrogenase abnormal, Pyrexia, General physical health deterioration, Haemoglobin abnormal, Platelet disorder, White blood cell count abnormal, Neutrophil count abnormal, |
||||
RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, CISPLATIN, |
||||
| 112 | 26538891 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 113 | 26538973 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 114 | 26539726 |
US |
78 | 1 |
General physical health deterioration, Pain, |
||||
POMALIDOMIDE, |
||||
| 115 | 26540184 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 116 | 26540210 |
EU |
73 | 2 |
Injection site abscess, Vascular encephalopathy, Essential hypertension, Injection site infection, Dysarthria, Urinary incontinence, General physical health deterioration, Malnutrition, Injection site pain, Hypertonia, Reduced facial expression, Facial asymmetry, Dyscalculia, Speech disorder, Dysphonia, Dysarthria, Disorientation, Aggression, Sensory disturbance, Fall, Anxiety, Memory impairment, Depression, Affective disorder, Confusional state, Drug resistance, Balance disorder, Behaviour disorder, Dehydration, Dysdiadochokinesis, Sarcopenia, Paraesthesia, Delirium, Injection site cellulitis, Device issue, Silent sinus syndrome, Muscular weakness, Fine motor skill dysfunction, Hyperreflexia, Cogwheel rigidity, Bradykinesia, Dyskinesia, Aphasia, Muscle atrophy, Echolalia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CLOZAPINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, RIVASTIGMINE, DALTEPARIN SODIUM, |
||||
| 117 | 26540646 |
CA |
57 | 1 |
Nausea, Oxygen saturation decreased, Pulmonary fibrosis, Rash, Therapeutic product effect delayed, Urticaria, Blood pressure diastolic increased, Blood pressure increased, Blood pressure systolic increased, General physical health deterioration, Heart rate increased, Pain in extremity, Weight increased, Prescribed overdose, Prescribed underdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, |
||||
| 118 | 26541075 |
US |
||
Ill-defined disorder, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 119 | 26541078 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 120 | 26541865 |
EU |
73 | 1 |
General physical health deterioration, Weight decreased, Decreased appetite, Fall, Hypokalaemia, |
||||
| 121 | 26541878 |
EU |
78 | 2 |
General physical health deterioration, Stoma site erythema, |
||||
| 122 | 26541901 |
US |
1 | |
Deafness, General physical health deterioration, |
||||
DAPAGLIFLOZIN, |
||||
| 123 | 26545974 |
50 | 2 | |
Anhedonia, Blood pressure decreased, Lethargy, Paraesthesia, Loss of personal independence in daily activities, General physical health deterioration, Drug interaction, |
||||
SEMAGLUTIDE, ARIPIPRAZOLE, |
||||
| 124 | 26531197 |
EU |
73 | 1 |
General physical health deterioration, Disease progression, |
||||
| 125 | 26531233 |
EU |
17 | 2 |
Colectomy, Anal ulcer, Large intestinal stenosis, Illness, Proctalgia, General physical health deterioration, Proctalgia, Vaginal discharge, Dyschezia, Defaecation urgency, Rectal discharge, Female genital tract fistula, Anal stenosis, Weight decreased, Anal abscess, Diarrhoea, Abdominal pain, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, AZATHIOPRINE, USTEKINUMAB, VEDOLIZUMAB, |
||||
| 126 | 26531364 |
JP |
7 | 1 |
General physical health deterioration, Dehydration, Acute kidney injury, COVID-19, Pyrexia, Decreased appetite, Malaise, |
||||
TELMISARTAN, AMLODIPINE BESYLATE, |
||||
| 127 | 26531426 |
US |
2 | |
Device issue, General physical health deterioration, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 128 | 26532622 |
EG |
59 | 2 |
Cancer fatigue, Hypophagia, Tachypnoea, Hypoalbuminaemia, General physical health deterioration, Dyspnoea, Fatigue, Febrile neutropenia, Leukopenia, Thrombocytopenia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 129 | 26532680 |
US |
81 | 2 |
General physical health deterioration, Pain, |
||||
ABATACEPT, |
||||
| 130 | 26532792 |
EU |
96 | 2 |
Lethargy, Oxygen saturation decreased, Renal impairment, General physical health deterioration, Toxicity to various agents, |
||||
MORPHINE SULFATE, FENTANYL, |
||||
| 131 | 26533145 |
CA |
55 | 1 |
General physical health deterioration, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CALCIUM, HYDROXYZINE, IRON, MIRTAZAPINE, PYRIDOXINE HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ERGOCALCIFEROL, THIAMINE HYDROCHLORIDE, PREDNISONE, |
||||
| 132 | 26533233 |
CA |
43 | 2 |
Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Depression, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Fatigue, Ear pain, Epilepsy, Exostosis, Facet joint syndrome, Feeling hot, Folliculitis, Fibromyalgia, Frequent bowel movements, Gait disturbance, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injection site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Liver function test increased, Live birth, Liver disorder, Normal newborn, Maternal exposure during pregnancy, Incorrect route of product administration, Drug ineffective, Intentional product use issue, Intentional product misuse, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, APREMILAST, APREMILAST, APREMILAST, ATOMOXETINE, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, MEPOLIZUMAB, BUPRENORPHINE, BUPRENORPHINE, ACETAMINOPHEN AND CODEINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 133 | 26533343 |
CA |
11 | 2 |
Haematochezia, General physical health deterioration, Poor venous access, |
||||
INFLIXIMAB, LANSOPRAZOLE, |
||||
| 134 | 26533503 |
US |
2 | |
Spinal cord compression, Spinal stenosis, Dizziness, Dysphagia, Metastases to central nervous system, Failure to thrive, Asthenia, General physical health deterioration, |
||||
| 135 | 26534061 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 136 | 26534329 |
US |
57 | 2 |
General physical health deterioration, |
||||
ABATACEPT, |
||||
| 137 | 26534654 |
EU |
60 | 2 |
Urticaria, Lung disorder, General physical health deterioration, Gait disturbance, Fatigue, Hypersensitivity, Renal failure, Hepatic failure, |
||||
TEPOTINIB HYDROCHLORIDE, |
||||
| 138 | 26534957 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 139 | 26535039 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 140 | 26535184 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 141 | 26535219 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 142 | 26535220 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 143 | 26535366 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 144 | 26526824 |
CA |
50 | 2 |
Haematochezia, General physical health deterioration, |
||||
VEDOLIZUMAB, |
||||
| 145 | 26527116 |
US |
75 | 1 |
General physical health deterioration, Gait inability, Loss of therapeutic response, |
||||
ABATACEPT, |
||||
| 146 | 26527302 |
US |
73 | 2 |
Myocardial infarction, General physical health deterioration, Cardiac disorder, Pericarditis, Circulatory collapse, Pericardial effusion, Asthenia, Product dispensing error, Product prescribing issue, |
||||
DAPAGLIFLOZIN, |
||||
| 147 | 26527355 |
CA |
40 | 2 |
Breast cancer stage III, Gait inability, Exposure during pregnancy, Vomiting, Musculoskeletal stiffness, Depression, Hand deformity, Pneumonia, Back injury, Abdominal distension, Weight increased, Dry mouth, Off label use, Blepharospasm, General physical health deterioration, Intentional product use issue, Dizziness, Duodenal ulcer perforation, Muscular weakness, Swelling, Facet joint syndrome, Asthenia, Nasopharyngitis, Hypercholesterolaemia, Blister, Neck pain, Gastrooesophageal reflux disease, Wound infection, Product label confusion, Pain in extremity, Synovitis, Wheezing, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, USTEKINUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, BOTULINUM TOXIN TYPE A, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, CALCIUM CARBONATE, CANDESARTAN, ERGOCALCIFEROL, BUPRENORPHINE, BUPRENORPHINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, OXYCODONE, OXYCODONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 148 | 26527879 |
CA |
70 | |
Wheezing, Body temperature increased, Cataract, Body temperature decreased, Atrioventricular block, Chest pain, Chills, Coronary artery occlusion, Dyspnoea, Dyspnoea exertional, Exercise tolerance decreased, Fall, Foot deformity, Forced expiratory volume decreased, General physical health deterioration, Hyperhidrosis, Hypoventilation, Limb injury, Malaise, Musculoskeletal chest pain, Obstructive airways disorder, Pain in extremity, Skin cancer, Sneezing, Stress, Throat irritation, Total lung capacity decreased, Tremor, Weight decreased, Myocardial infarction, Pneumonia, Cough, Fatigue, Lower respiratory tract infection, Viral infection, Incorrect dose administered, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MEPOLIZUMAB, |
||||
| 149 | 26527952 |
CA |
76 | 2 |
Arthralgia, Drug ineffective, Fatigue, Myalgia, Pain, General physical health deterioration, Erythema, Hypersensitivity, Tooth disorder, |
||||
RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 150 | 26527977 |
CA |
2 | |
General physical health deterioration, Cognitive disorder, |
||||
VEDOLIZUMAB, |
||||
| 151 | 26528041 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 152 | 26528174 |
JP |
78 | 2 |
Respiratory failure, General physical health deterioration, |
||||
TREPROSTINIL, TREPROSTINIL, |
||||
| 153 | 26528615 |
EG |
45 | 2 |
Thrombocytopenia, Haematuria, Acute kidney injury, Hypoalbuminaemia, Hypocalcaemia, General physical health deterioration, Normochromic normocytic anaemia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, FENTANYL, FENTANYL, FENTANYL, FENTANYL, |
||||
| 154 | 26528642 |
US |
44 | 2 |
Fatigue, Depressed level of consciousness, Disturbance in attention, General physical health deterioration, Impaired work ability, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 155 | 26528724 |
CA |
43 | 2 |
Blepharospasm, Abdominal pain upper, Epilepsy, Gastrooesophageal reflux disease, Pain, Paraesthesia, Vomiting, Taste disorder, Drug intolerance, Abdominal discomfort, Anti-cyclic citrullinated peptide antibody positive, Alopecia, Back injury, Arthralgia, Arthropathy, Drug hypersensitivity, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Confusional state, Depression, Diarrhoea, Duodenal ulcer perforation, Dizziness, Fibromyalgia, Dry mouth, Gait inability, Facet joint syndrome, Folliculitis, Pain in extremity, General physical health deterioration, Maternal exposure during pregnancy, Live birth, Subcutaneous drug absorption impaired, Rash vesicular, Fatigue, Pustular psoriasis, Psoriasis, Malaise, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, RITUXIMAB, OXYCODONE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MAGNESIUM, |
||||
| 156 | 26529128 |
CA |
43 | 2 |
Condition aggravated, Drug ineffective, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Joint range of motion decreased, Joint swelling, Lip dry, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 157 | 26529379 |
58 | ||
Fatigue, Malaise, Weight decreased, Adverse event, General physical health deterioration, Decreased appetite, Abdominal pain, Diarrhoea, Dizziness, Nausea, Abdominal pain upper, Constipation, Therapy interrupted, |
||||
RESMETIROM, RESMETIROM, DULOXETINE HYDROCHLORIDE, DULOXETINE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LISDEXAMFETAMINE DIMESYLATE, TIRZEPATIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, TIRZEPATIDE, |
||||
| 158 | 26529524 |
EU |
73 | 1 |
Pneumonia, Decubitus ulcer, Contraindicated product administered, Secretion discharge, Hypokinesia, Asthenia, Nasopharyngitis, Akinesia, Psychomotor hyperactivity, Dyskinesia, Psychomotor hyperactivity, Weight decreased, Dysarthria, Nosocomial infection, Hyperkinesia, Somnolence, General physical health deterioration, Underdose, Incorrect dose administered, Device use error, Device issue, |
||||
CLINDAMYCIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMANTADINE, AMLODIPINE, BISOPROLOL FUMARATE, CANDESARTAN, DARIFENACIN HYDROBROMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MIRTAZAPINE, ROTIGOTINE, OXAZEPAM, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, PANTOPRAZOLE, PREGABALIN, SERTRALINE, SIMVASTATIN, TAMSULOSIN HYDROCHLORIDE, |
||||
| 159 | 26529616 |
EU |
1 | |
Myasthenia gravis crisis, General physical health deterioration, |
||||
EFGARTIGIMOD ALFA, |
||||
| 160 | 26529917 |
CN |
66 | 2 |
Gait disturbance, General physical health deterioration, Pain, |
||||
TERIPARATIDE, |
||||
| 161 | 26530182 |
US |
62 | 2 |
General physical health deterioration, |
||||
ABATACEPT, ABATACEPT, |
||||
| 162 | 26530955 |
CA |
51 | |
Condition aggravated, Cognitive disorder, General physical health deterioration, Pneumonia, Bacterial infection, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, |
||||
| 163 | 26533192 |
2 | ||
COVID-19, Urinary tract infection, Constipation, Cardiac flutter, Joint swelling, Peripheral swelling, Dyspnoea, Depressed mood, Chest pain, Fatigue, Syncope, General physical health deterioration, |
||||
DENOSUMAB, FUROSEMIDE, POLYETHYLENE GLYCOL 3350, TREPROSTINIL, |
||||
| 164 | 26522583 |
EU |
77 | 1 |
General physical health deterioration, Hypotension, Obstruction, Pneumonia, Renal impairment, Blood potassium increased, Coma, |
||||
| 165 | 26523202 |
IN |
1 | |
General physical health deterioration, |
||||
DURVALUMAB, |
||||
| 166 | 26523683 |
|||
General physical health deterioration, |
||||
CERTOLIZUMAB PEGOL, FOLIC ACID, MAGNESIUM, ROSUVASTATIN, ERGOCALCIFEROL, |
||||
| 167 | 26523823 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 168 | 26523918 |
EU |
17 | |
Colectomy, Anal ulcer, Large intestinal stenosis, Anal stenosis, Anal abscess, Diarrhoea, Proctalgia, General physical health deterioration, Proctalgia, Vaginal discharge, Weight decreased, Dyschezia, Defaecation urgency, Rectal discharge, Female genital tract fistula, Abdominal pain, Illness, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, USTEKINUMAB, AZATHIOPRINE, VEDOLIZUMAB, |
||||
| 169 | 26524028 |
1 | ||
General physical health deterioration, Infection, |
||||
| 170 | 26524368 |
CA |
40 | 2 |
Abdominal distension, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Depression, Dizziness, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Hand deformity, Hypercholesterolaemia, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Pain in extremity, Pneumonia, Swelling, Synovitis, Vomiting, Wound infection, Weight increased, Wheezing, Exposure during pregnancy, Product label confusion, Intentional product use issue, Off label use, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, USTEKINUMAB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, CALCIUM CARBONATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, NAPROXEN, NAPROXEN SODIUM, |
||||
| 171 | 26525116 |
CA |
43 | 2 |
Joint range of motion decreased, Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Blepharospasm, Arthralgia, Blister, Blood cholesterol increased, Contraindicated product administered, Infusion related reaction, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypocholesterolaemia, Muscle injury, Impaired healing, Irritable bowel syndrome, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Osteoarthritis, Migraine, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, |
||||
| 172 | 26525257 |
CA |
63 | 2 |
Adenocarcinoma of the cervix, Cervix carcinoma stage IV, Drug-induced liver injury, General physical health deterioration, Myasthenia gravis, Myocarditis, Myopathy, |
||||
DOSTARLIMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 173 | 26526129 |
37 | 2 | |
Product use issue, General physical health deterioration, |
||||
SOTATERCEPT-CSRK, |
||||
| 174 | 26526461 |
EU |
17 | 2 |
Large intestinal stenosis, Anal ulcer, Rectal tenesmus, Secretion discharge, General physical health deterioration, Genital abscess, Female genital tract fistula, Dyschezia, Abdominal pain, Diarrhoea, Proctalgia, Drug ineffective, Anal abscess, Weight decreased, Colitis, Female genital tract fistula, Anal stenosis, Anal fistula, |
||||
ADALIMUMAB, USTEKINUMAB, VEDOLIZUMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 175 | 26526550 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, LEFLUNOMIDE, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 176 | 26526703 |
US |
64 | 2 |
General physical health deterioration, |
||||
ABATACEPT, |
||||
| 177 | 26526704 |
US |
2 | |
General physical health deterioration, |
||||
RAVULIZUMAB, |
||||
| 178 | 26526746 |
US |
62 | 1 |
Death, Paralysis, Drug ineffective, General physical health deterioration, |
||||
TOFERSEN, |
||||
| 179 | 26521186 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 180 | 26521192 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 181 | 26521203 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 182 | 26521428 |
EU |
2 | |
General physical health deterioration, |
||||
| 183 | 26521527 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 184 | 26521795 |
US |
65 | 1 |
General physical health deterioration, Product dose omission issue, |
||||
DUPILUMAB, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, ROSUVASTATIN CALCIUM, ROFLUMILAST, ALBUTEROL SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FUROSEMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ALBUTEROL SULFATE, WARFARIN SODIUM, WARFARIN, PREDNISONE, PREGABALIN, EPINEPHRINE, FAMOTIDINE, CARVEDILOL, |
||||
| 185 | 26517014 |
US |
71 | 2 |
Pain, General physical health deterioration, |
||||
ABATACEPT, |
||||
| 186 | 26517218 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 187 | 26517270 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 188 | 26517304 |
CA |
43 | 2 |
Joint range of motion decreased, Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Blepharospasm, Arthralgia, Blister, Blood cholesterol increased, Contraindicated product administered, Infusion related reaction, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypocholesterolaemia, Muscle injury, Impaired healing, Irritable bowel syndrome, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Osteoarthritis, Migraine, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Off label use, |
||||
SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, |
||||
| 189 | 26517383 |
66 | ||
General physical health deterioration, Product dose omission issue, Device mechanical issue, Device delivery system issue, |
||||
INSULIN GLULISINE, |
||||
| 190 | 26517391 |
EU |
78 | 2 |
General physical health deterioration, Pancytopenia, Urosepsis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SACUBITRIL AND VALSARTAN, BISOPROLOL FUMARATE, FUROSEMIDE, PANTOPRAZOLE, |
||||
| 191 | 26517397 |
US |
56 | 2 |
Pain, General physical health deterioration, |
||||
ABATACEPT, |
||||
| 192 | 26517478 |
55 | ||
General physical health deterioration, Drug dose omission by device, Device mechanical issue, |
||||
ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, |
||||
| 193 | 26517587 |
US |
74 | 1 |
Adverse drug reaction, Ill-defined disorder, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 194 | 26517764 |
EU |
54 | 1 |
Respiratory failure, Drug ineffective, Sepsis, General physical health deterioration, |
||||
FILGRASTIM, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 195 | 26517935 |
EU |
2 | |
General physical health deterioration, Adrenal insufficiency, Adrenocortical insufficiency acute, Norovirus infection, Adrenocortical insufficiency acute, |
||||
PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 196 | 26518342 |
US |
2 | |
General physical health deterioration, |
||||
DAPAGLIFLOZIN, |
||||
| 197 | 26518654 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 198 | 26519098 |
EU |
86 | 2 |
Immunotoxicity, General physical health deterioration, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), DOSTARLIMAB, |
||||
| 199 | 26519327 |
EU |
2 | |
Diffuse large B-cell lymphoma, Disease progression, General physical health deterioration, Drug ineffective, |
||||
OXALIPLATIN, OXALIPLATIN, RITUXIMAB, RITUXIMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 200 | 26519364 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28